Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Microsoft
MSFT
|
+$633M |
| 3 |
Alibaba
BABA
|
+$501M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$484M |
| 5 |
Apple
AAPL
|
+$456M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$622M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$597M |
| 3 |
Comcast
CMCSA
|
+$461M |
| 4 |
UnitedHealth
UNH
|
+$409M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.08% |
| 2 | Consumer Discretionary | 2.25% |
| 3 | Financials | 2.23% |
| 4 | Healthcare | 2.22% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
CALL
Dave & Buster's
PLAY
$354M
| $16.2M | ﹤0.01% |
421,900
-121,800
| -22% | -$4.41M |
|
2227
PUT
Tandem Diabetes Care
TNDM
$1.58B
| $16.2M | ﹤0.01% |
135,400
+34,400
| +34% | +$3.79M |
|
|
DTRTU
2228
DELISTED
DTRT Health Acquisition Corp. Unit
DTRTU
| $16.2M | ﹤0.01% |
+1,601,718
| New | +$16.1M |
|
2229
CALL
Editas Medicine
EDIT
$433M
| $16.2M | ﹤0.01% |
393,300
+62,000
| +19% | +$3.4M |
|
2230
Zebra Technologies
ZBRA
$17.8B
| $16.2M | ﹤0.01% |
31,341
-1,877
| -6% | -$1.05M |
|
2231
Avis
CAR
$4.87B
| $16.1M | ﹤0.01% |
138,557
-39,699
| -22% | -$3.5M |
|
|
CMRC
2232
Commerce.com Inc Series 1
CMRC
$181M
| $16.1M | ﹤0.01% |
318,607
-82,348
| -21% | -$5.02M |
|
2233
Albemarle
ALB
$16.1B
| $16.1M | ﹤0.01% |
+73,676
| New | +$15.7M |
|
2234
CALL
HSBC
HSBC
$357B
| $16.1M | ﹤0.01% |
616,800
+218,000
| +55% | +$5.94M |
|
2235
PUT
Lumentum
LITE
$82.1B
| $16.1M | ﹤0.01% |
192,800
+23,100
| +14% | +$1.94M |
|
2236
PUT
ChargePoint
CHPT
$160M
| $16.1M | ﹤0.01% |
40,280
+7,615
| +23% | +$3.54M |
|
2237
BuzzFeed
BZFD
$92.5M
| $16.1M | ﹤0.01% |
406,203
+95,596
| +31% | +$3.78M |
|
2238
Trupanion
TRUP
$1.34B
| $16.1M | ﹤0.01% |
207,290
+185,731
| +862% | +$18.3M |
|
|
BECN
2239
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $16.1M | ﹤0.01% |
336,785
-75,874
| -18% | -$3.93M |
|
2240
CALL
Doximity
DOCS
$4.42B
| $16.1M | ﹤0.01% |
+199,300
| New | +$14.6M |
|
2241
CALL
Tenet Healthcare
THC
$21.6B
| $16.1M | ﹤0.01% |
242,000
+38,000
| +19% | +$2.7M |
|
|
SPWR
2242
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $16.1M | ﹤0.01% |
708,700
-28,700
| -4% | -$671K |
|
|
TPTX
2243
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $16.1M | ﹤0.01% |
241,948
+234,856
| +3,312% | +$16.7M |
|
2244
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.43B
| $16.1M | ﹤0.01% |
425,461
+367,212
| +630% | +$14M |
|
2245
CALL
PPG Industries
PPG
$25.4B
| $16.1M | ﹤0.01% |
112,300
+5,000
| +5% | +$802K |
|
2246
BridgeBio Pharma
BBIO
$15.6B
| $16.1M | ﹤0.01% |
342,548
-70,030
| -17% | -$3.75M |
|
2247
PUT
C.H. Robinson
CHRW
$17.4B
| $16M | ﹤0.01% |
184,400
+10,100
| +6% | +$914K |
|
2248
Pulmonx
LUNG
$104M
| $16M | ﹤0.01% |
445,811
+178,267
| +67% | +$7.01M |
|
2249
PUT
Truist Financial
TFC
$64.9B
| $16M | ﹤0.01% |
273,348
-20,852
| -7% | -$1.17M |
|
2250
Reynolds Consumer Products
REYN
$5.53B
| $16M | ﹤0.01% |
586,272
+82,123
| +16% | +$2.35M |
|
Similar funds
Ken Griffin's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.
- Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
- Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
- Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
- Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
- Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
- Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
- Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.